Saffron Walden, United Kingdom

Chris Knight



 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Essex, GB (2012 - 2015)
  • Saffron Walden, IT (2015)
  • Saffron Walden, GB (2015 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Chris Knight - Innovator in Vasopressin Receptor Antagonists

Introduction

Chris Knight, an accomplished inventor based in Saffron Walden, GB, holds an impressive portfolio of 14 patents. His contributions have primarily focused on pharmacological innovations, particularly in the field of vasopressin receptor antagonists.

Latest Patents

Among Knight's latest patents are significant advancements in vasopressin receptor antagonists and products and methods related to them. These compounds, designed to antagonize vasopressin receptors—specifically the V1a receptor—are detailed in his patents. The documentation articulates that the compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, with specific definitions for Q, R, and X. These innovations not only improve therapeutic applications but also pave the way for new syntheses in the pharmaceutical realm.

Career Highlights

Chris Knight’s career has been marked by his association with notable companies such as Chiesi Farmaceutici S.p.a. and Merck Serono S.A., where he has applied his expertise to further advancements in healthcare and medicinal chemistry. His involvement in these reputable organizations underscores his dedication and impact on the field.

Collaborations

Throughout his illustrious career, Chris has collaborated with esteemed colleagues like Fabio Rancati and Ian Linney. Together, they have combined their expertise to drive innovation in pharmacology and enhance the application of vasopressin receptor antagonists.

Conclusion

Chris Knight embodies the spirit of innovation, driving advancements in pharmaceutical sciences through his impressive collection of patents and collaborations. His work on vasopressin receptor antagonists is particularly notable, showcasing his commitment to improving therapeutic options for patients. The future of this field will undoubtedly benefit from his continued contributions and inventive spirit.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…